Comparing 15D and SF-6D Performance in Fragility Wrist and Hip Fracture Patients in a Two-Year Follow-Up Case-Control Study

Dec 1, 2012, 00:00
10.1016/j.jval.2012.08.2200
https://www.valueinhealthjournal.com/article/S1098-3015(12)03920-4/fulltext
Title : Comparing 15D and SF-6D Performance in Fragility Wrist and Hip Fracture Patients in a Two-Year Follow-Up Case-Control Study
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03920-4&doi=10.1016/j.jval.2012.08.2200
First page : 1100
Section Title : Preference-Based Assessments
Open access? : No
Section Order : 13

Objectives

To examine and compare the two utility and health-related quality-of-life (HRQOL) measures 15D and (SF-6D) in fragility wrist and hip fracture patients and controls, study the responsiveness of 15D and SF-6D, and examine the impact of these fractures on changes in 15D and SF-6D scores over 2 years.

Methods

A total of 152 wrist fracture patients and 164 controls and 61 hip fracture patients and 61 controls with 15D and SF-6D scores were studied.

Results

The mean 15D score decreased significantly in wrist fracture patients between baseline and 2-year follow-up (P=0.003). A wrist fracture was a significant predictor of a decrease in 15D scores 2 years after fracture (B=−0.016; P=0.049), along with low body mass index (B=−0.002; P=0.009). In hip fracture patients, both 15D and SF-6D scores decreased significantly (P P=0.001) scores.

Conclusions

Our data suggest that a fragility wrist fracture has a long-term negative effect on HRQOL, but not as strong as for fragility hip fractures. 15D seems to be more responsive than SF-6D when assessing HRQOL in patients with fragility fractures.

Categories :
  • Health State Utilities
  • Musculoskeletal Disorders
  • Patient-Centered Research
  • Patient-reported Outcomes & Quality of Life Outcomes
  • Specific Diseases & Conditions
Tags :
  • 15D
  • decision making
  • health-related quality of life
  • osteoporosis
  • SF-36
Regions :
  • Africa
  • Eastern and Central Europe
  • Middle East
  • Western Europe
ViH Article Tags :